Patel Anish Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$3.36M

Insider Activity of Patel Anish

According to the SEC Form 4 filings, Patel Anish, being in a position of

  1. CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 61630 shares for $1.61M,
    over all time since 2024-01-22, has bought 0 shares, and sold 248847 shares for $5.75M.

Biography of Patel Anish

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,607,8693100

Comparison of Insiders on Amount of Buys and Sells

2026-01-09SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
48,300
0.0876%
$27.99$1.35M+63.58%
2025-12-08SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,663
0.0115%
$21.02$140,073+102.63%
2025-11-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0084%
$17.40$116,034+132.44%
2025-10-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0112%
$20.10$133,993+87.92%
2025-09-08SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0114%
$20.24$134,957+47.05%
2025-08-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0115%
$18.24$121,616+51.12%
2025-07-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0114%
$19.79$131,951+18.68%
2025-06-09SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0136%
$20.34$135,574+6.98%
2025-05-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0137%
$18.39$122,579+16.58%
2025-04-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0137%
$18.04$120,269+14.8%
2025-04-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
3,756
0.0076%
$17.81$66,889+14.8%
2025-03-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0137%
$21.44$142,936-3.33%
2025-02-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
6,667
0.0133%
$21.93$146,206-7.82%
2025-01-07SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
28,367
0.0579%
$24.18$685,868-15%
2024-10-18SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
716
0.0018%
$30.00$21,483-27.97%
2024-07-16SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
1,547
0.0032%
$25.01$38,692-10.77%
2024-07-15SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
30,978
0.0651%
$25.05$776,039-12.35%
2024-07-12SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
17,475
0.0368%
$25.07$438,095-11.08%
2024-06-06SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
1,133
0.0019%
$20.06$22,722+9.68%
2024-05-14SaleEnliven Therapeutics, Inc.
ELVN
CHIEF OPERATING OFFICER
1,107
0.0023%
$25.00$27,675-6.01%
Total: 27
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.